Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Manuel Enrique Jiménez-Mejías"'
Autor:
Andrea Miró-Canturri, Andrea Vila-Domínguez, Marta Caretero-Ledesma, Rafael Ayerbe-Algaba, Jerónimo Pachón, Manuel Enrique Jiménez-Mejías, Younes Smani
Publikováno v:
Microbiology Spectrum, Vol 9, Iss 2 (2021)
ABSTRACT Repurposing drugs provides a new approach to the fight against multidrug-resistant (MDR) bacteria. We have reported that three major tamoxifen metabolites, N-desmethyltamoxifen (DTAM), 4-hydroxytamoxifen (HTAM), and endoxifen (ENDX), present
Externí odkaz:
https://doaj.org/article/1bea7b9b664442dca51d63681c5ad2f9
Autor:
Andrea Miró-Canturri, Rafael Ayerbe-Algaba, Manuel Enrique Jiménez-Mejías, Jerónimo Pachón, Younes Smani
Publikováno v:
Antibiotics, Vol 10, Iss 2, p 194 (2021)
The stimulation of the immune response to prevent the progression of an infection may be an adjuvant to antimicrobial treatment. Here, we aimed to evaluate the efficacy of lysophosphatidylcholine (LPC) treatment in combination with colistin in murine
Externí odkaz:
https://doaj.org/article/70bb8289dbb0440494fed46340d72ed7
Autor:
Rafael Ayerbe-Algaba, María Luisa Gil-Marqués, Manuel Enrique Jiménez-Mejías, Viviana Sánchez-Encinales, Raquel Parra-Millán, María Eugenia Pachón-Ibáñez, Jerónimo Pachón, Younes Smani
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 8 (2018)
Colistin is among the few antibiotics effective against multidrug-resistant Acinetobacter baumannii and Klebsiella pneumoniae clinical isolates. However, in the last few years, colistin-resistant A. baumannii and K. pneumoniae strains have emerged. T
Externí odkaz:
https://doaj.org/article/3d5d2261943d439d93b4628f65286cba
Autor:
Vicente, Pintado, Rosario, Pazos, Manuel Enrique, Jiménez-Mejías, Azucena, Rodríguez-Guardado, Beatriz, Díaz-Pollán, Carmen, Cabellos, Juan Manuel, García-Lechuz, Jaime, Lora-Tamayo, Pere, Domingo, Elena, Muñez, Diego, Domingo, Fernando, González-Romo, José Antonio, Lepe-Jiménez, Carlos, Rodríguez-Lucas, Eulalia, Valencia, Iván, Pelegrín, Fernando, Chaves, Virginia, Pomar, Antonio, Ramos, Teresa, Alarcón, Elisa, Pérez-Cecilia
Publikováno v:
Infectious diseases (London, England). 52(11)
Linezolid has good penetration to the meninges and could be an alternative for treatment ofRetrospective multicenter cohort study of 26 adults treated with linezolid, derived from a cohort of 350 cases ofThere were 15 males (58%) and mean age was 47.
Autor:
Emilio Bouza, Maricela Valerio, Alex Soriano, Laura Morata, Enrique García Carus, Carmen Rodríguez-González, Ma Carmen Hidalgo-Tenorio, Antonio Plata, Patricia Muñoz, Antonio Vena, Ana Alvarez-Uria, Ana Fernández-Cruz, Ascensión Arroyo Nieto, Arturo Artero, José María Barbero Allende, Enrique Bernal Morell, Francisco Javier Candel-González, Laura Castelo, Javier Cobo, Maria del Carmen Gálvez Contreras, Roberto Güerri Fernández, Juan Pablo Horcajada, Pablo Guisado-Vasco, Juan Emilio Losa, Rafael Hervás, Simona Mihaela Iftimie, Manuel Enrique Jiménez Mejías, Francisco Jover, José Luis Lamas Ferreiro, Ana B. Lozano Serrano, Eduardo Malmierca, Mar Masiá, Maria Rosa Oltra Sempere, Alicia Rico Nieto, Dolors Rodriguez-Pardo, Sergio J. Rodriguez Alvarez, Rafael San Juan, Cristina Sarria Cepeda, María Antonia Sepúlveda Berrocal, Beatriz Sobrino, Luisa Sorlí
Publikováno v:
International journal of antimicrobial agents. 51(4)
Dalbavancin is a lipoglycopeptide with a very prolonged half-life enabling treatment with a single intravenous administration that has been approved to treat complicated skin and soft-tissue infections. Information on the efficacy and safety of dalba
Autor:
Mónica Rivero-Garvía, Javier Márquez-Rivas, Manuel Enrique Jiménez-Mejías, Olaf Neth, Ana Belén Rueda-Torres
Publikováno v:
Acta Neurochirurgica. 153:1157-1157
Autor:
María Luisa Limón Mirón, José Andrés Moreno Nogueira, Manuel Enrique Jiménez Mejías, Manuel Chaves Conde
Publikováno v:
Revista de Oncología. 3:159-160
A case of Leuconostoc spp. bacteremia in a patient with neutropenia secondary to chemotherapy is considered. The predisposing factors in this case were neutropenia, presence of central venous catheter and previous treatment with broad-spectrum antibi
Autor:
Andrea Miró-Canturri, Rafael Ayerbe-Algaba, Raquel del Toro, Manuel Enrique-Jiménez Mejías, Jerónimo Pachón, Younes Smani
Publikováno v:
Pharmaceuticals, Vol 14, Iss 6, p 507 (2021)
The development of new strategic therapies for multidrug-resistant bacteria, like the use of non-antimicrobial approaches and/or drugs repurposed to be used as monotherapies or in combination with clinically relevant antibiotics, has become urgent. A
Externí odkaz:
https://doaj.org/article/12c84283491b4fa8ae7b64002300fa61